Olympus announced that it launched a new hemostasis clip to meet the needs of gastrointestinal (GI) endoscopists. The company's Retentia HemoClip offers 360° rotation and an intuitive one-step deployment. This provides control over placement with three different sizes to accommodate a variety of closure applications. Retentia HemoClip … [Read more...] about Olympus launches single-use hemostasis clip
Business
J&J’s Shockwave Medical launches new IVL catheter
Johnson & Johnson MedTech‘s Shockwave Medical today announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter. The system is designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-balloon IVL platform delivers a similar … [Read more...] about J&J’s Shockwave Medical launches new IVL catheter
Boston Scientific to acquire renal denervation company SoniVie
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie. Marlborough, Massachusetts-based Boston Scientific is a strategic investor in SoniVie, holding about a 10% equity stake. With this stake, the transaction features an upfront payment of approximately $360 million for the 90% … [Read more...] about Boston Scientific to acquire renal denervation company SoniVie
Adagio Medical to restructure, reduce workforce
Adagio Medical (Nasdaq:ADGM) announced today that it plans a corporate restructuring and realignment of resources. The Laguna Hills, California–based company, which develops catheter ablation technologies for treating cardiac arrhythmias, wants to prioritize its FULCRUM-VT pivotal FDA investigational device exemption (IDE) clinical trial … [Read more...] about Adagio Medical to restructure, reduce workforce
Biotronik shifts strategy to focus on implantable devices
Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to Teleflex. This deal comes as part of a major change at Teleflex, too, as the company today announced plans to separate into two separate businesses. Biotronik said its shift aims to strengthen its leadership in active … [Read more...] about Biotronik shifts strategy to focus on implantable devices
Teleflex to separate into two publicly traded companies
Teleflex [WtwhTicker symbol="TFX"](NYSE: TFX)[/WtwhTicker] announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly traded company. The company's board authorized management to pursue a plan to separate the businesses via a distribution of newly issued shares of "NewCo" to shareholders that is … [Read more...] about Teleflex to separate into two publicly traded companies
Jabil partners with Midwest Interventional Systems on catheter tech
Jabil and Midwest Interventional Systems (MIS) have entered into a collaborative agreement that will expand what the two contract development and manufacturing organizations can do for medical device developers, including those working on minimally invasive systems. St. Petersburg, Florida-based Jabil and Maple Grove, Minnesota-based MIS said … [Read more...] about Jabil partners with Midwest Interventional Systems on catheter tech
Johnson & Johnson MedTech resumes Varipulse sales after stroke-related pause
This article originally ran on Feb. 15, 2025. It was updated on Feb. 28 with additional information from the FDA. Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a temporary pause. Last month, the medtech giant said it temporarily halted all U.S. cases using its … [Read more...] about Johnson & Johnson MedTech resumes Varipulse sales after stroke-related pause
Johnson & Johnson MedTech launches catheter system for stroke
Johnson & Johnson MedTech [WtwhTicker symbol="JNJ"](NYSE: JNJ)[/WtwhTicker] announced today that it launched the CereGlide 92 catheter system for treating acute ischemic stroke. The launch comes just one day after media reports suggested that the company wants to sell its Cerenovus stroke business, the unit that makes the CereGlide … [Read more...] about Johnson & Johnson MedTech launches catheter system for stroke
RenovoRx prices $12.1M offering
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 million. Mountain View, California-based RenovoRx priced more than 11.5 million shares of common stock at $1.05 per share. It expects the proceeds to total approximately $12.1 million before deducting underwriting discounts, … [Read more...] about RenovoRx prices $12.1M offering
